MitoQ trial aims to ease leg pain for PAD patients
NCT ID NCT06409949
First seen Feb 27, 2026 · Last updated Apr 28, 2026 · Updated 10 times
Summary
This study tests whether taking MitoQ for six months can improve walking ability and reduce leg pain in people with peripheral artery disease (PAD). Researchers will measure walking distance on a treadmill and during a 6-minute walk, as well as daily activity and quality of life. The study involves 60 adults with PAD who experience leg cramps while walking.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERIPHERAL ARTERIAL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
VA Medical Center
RECRUITINGOmaha, Nebraska, 68105, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.